We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases / Novasep announces 2016 financial results

Novasep announces 2016 financial results

Novasep announces 2016 financial results
31 May 2017

Sales are up 3.5% at 271 M€
EBITDA is stable at 28 M€

Lyon, France, May 31, 2017 – Novasep, a leading supplier of services and technologies for the life sciences industry, today announces for 2016 a +3.5% increase of sales with a stable EBITDA at € 28 million.

In 2016, Novasep’s contract and development manufacturing services business (CDMO) continued its transition towards high profitability sectors. Successes have come from key projects such as the OMEGA-3 purification contract and from the general sales and assets reorganization. This supports the Group’s ability to develop in services for growing sectors of the Pharmaceutical industry such as Antibody Drug Conjugates, Monoclonal Antibodies and Viral Vector based therapies.

Over the same period, the engineering and purification equipment services business showed a strong recovery as compared to 2015, thanks to the effective development of the Complete Process Line strategy. The Group has successfully divested its non-strategic stakes in TangenX Technology Corporation at the end of 2016.

Dr Michel Spagnol, CEO and Chairman of Novasep, commented: “Our 2016 results demonstrate again the relevance of Novasep’s business model. We benefitted from a very strong activity in Biopharma, particularly in gene therapies, and this contributed to balance adverse conditions in the agrochemical market."

Outlook for 2017
Looking ahead to 2017, Novasep anticipates further revenue growth thanks to its robust backlog for both manufacturing and engineering services businesses and to the resilience of its business model despite changing market conditions.

Novasep combines great innovation power, a strong presence in the most dynamic markets and a streamlined business organization.”, Spagnol added: “We believe we are well on track to achieve our goals in terms of business and financial growth.”

 

2016 FInancial Results V4

 

Press Contact:
Sophie Baudouin
Director Communication & Marketing
+33 6 32 08 20 24

 

About Novasep

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries.

 

Novasep Icon PDFDeutsch

Novasep Icon PDFFrançais

 


Back to full list of events

You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!